Trial · NCT03116347
Results by group116
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 116
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Safety: Number of Participants With Any Severe Related Treatment-emergent Adverse Events (TEAEs) Per Infusion (Excluding Infections) | HyQvia New Starters | 1 | Participants | ||
| Safety: Number of Participants With Any Severe Related Treatment-emergent Adverse Events (TEAEs) Per Infusion (Excluding Infections) | HyQvia Pre-treated | 0 | Participants | ||
| Safety: Rate of Any Severe Related TEAEs Per Infusion (Excluding Infections) | HyQvia New Starters | 0.004 | Number of Severe Related TEAEs/Infusion | ||
| Safety: Rate of Any Severe Related TEAEs Per Infusion (Excluding Infections) | HyQvia Pre-treated | 0 | Number of Severe Related TEAEs/Infusion | ||
| Safety: Number of Participants With Any Related Serious TEAEs Per Infusion (Excluding Infections) | HyQvia New Starters | 0 | Participants | ||
| Safety: Number of Participants With Any Related Serious TEAEs Per Infusion (Excluding Infections) | HyQvia Pre-treated | 0 | Participants | ||
| Safety: Rate of Any Related Serious TEAEs Per Infusion (Excluding Infections) | HyQvia New Starters | 0 | Number of Related Serious TEAEs/Infusion | ||
| Safety: Rate of Any Related Serious TEAEs Per Infusion (Excluding Infections) | HyQvia Pre-treated | 0 | Number of Related Serious TEAEs/Infusion | ||
| Efficacy: Change From Baseline in Total Serum Trough Levels of Immunoglobulin G (IgG) at Month 12 | HyQvia New Starters | 0.035 | Standard Deviation 1.6983 | Gram per liter (g/L) | |
| Efficacy: Change From Baseline in Total Serum Trough Levels of Immunoglobulin G (IgG) at Month 12 | HyQvia Pre-treated | -0.709 | Standard Deviation 2.6576 | Gram per liter (g/L) | |
| Efficacy: Change From Baseline in Serum Trough Levels of IgG Subclasses at Month 12 | HyQvia New Starters | IgG Subclass 1 : Changed at Month 12 | -0.813 | Standard Deviation 1.1087 | g/L |
| Efficacy: Change From Baseline in Serum Trough Levels of IgG Subclasses at Month 12 | HyQvia Pre-treated | IgG Subclass 1 : Changed at Month 12 | -0.467 | Standard Deviation 1.5976 | g/L |
| Efficacy: Change From Baseline in Serum Trough Levels of IgG Subclasses at Month 12 | HyQvia New Starters | IgG Subclass 2 : Changed at Month 12 | 0.000 | Standard Deviation 0.8944 | g/L |
| Efficacy: Change From Baseline in Serum Trough Levels of IgG Subclasses at Month 12 | HyQvia Pre-treated | IgG Subclass 2 : Changed at Month 12 | -0.667 | Standard Deviation 1.3452 | g/L |
| Efficacy: Change From Baseline in Serum Trough Levels of IgG Subclasses at Month 12 | HyQvia New Starters | IgG Subclass 3 : Changed at Month 12 | 0.000 | Standard Deviation 0.3651 | g/L |
| Efficacy: Change From Baseline in Serum Trough Levels of IgG Subclasses at Month 12 | HyQvia Pre-treated | IgG Subclass 3 : Changed at Month 12 | 0.133 | Standard Deviation 0.3519 | g/L |
| Efficacy: Change From Baseline in Serum Trough Levels of IgG Subclasses at Month 12 | HyQvia New Starters | IgG Subclass 4 : Changed at Month 12 | 0.094 | Standard Deviation 0.0854 | g/L |
| Efficacy: Change From Baseline in Serum Trough Levels of IgG Subclasses at Month 12 | HyQvia Pre-treated | IgG Subclass 4 : Changed at Month 12 | -0.027 | Standard Deviation 0.0799 | g/L |
| Efficacy: Change From Baseline in Trough Levels of Specific Antibodies to Clostridium Tetani Toxoid IgG at Month 12 | HyQvia New Starters | -0.218 | Standard Deviation 0.9345 | IU/ml | |
| Efficacy: Change From Baseline in Trough Levels of Specific Antibodies to Hepatitis B Virus (HBV) at Month 12 | HyQvia New Starters | 167.875 | Standard Deviation 147.4887 | International units per liter (IU/L) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03116347/results